David Y. Liu, Chief Scientific Officer at Protagonist Therapeutics, Inc (PTGX), sold 3,500 shares at $12.68 ($44K) on 2017-07-10, disclosed to the SEC on 2017-07-12.
Scheduled sale ($44k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PTGX | SELL | 2019-03-04 | $7K | — | Filing → |
| PTGX | SELL | 2019-02-08 | $30K | — | Filing → |
| PTGX | SELL | 2018-03-13 | $75K | — | Filing → |